Tauns Laboratories

197A.TTSE STANDARDPharmaceutical

Filed as TAUNS Laboratories,Inc. (2024-09–2026-09)

Major holders (5%+) · 2

Holder	Stake	Change	Filed
CJP III GP Ltd.	39.29%	-2.89pp	2026-10-19
Masaki Nonaka	29.69%	-0.78pp	2025-09-25

Each holder's own ratio from its most recent large-shareholding report.

Former and minor holders (below 5%) · 1

CCP Japan Ltd 0.24% 2025-12-24

Ownership history · 13

Filed	Holder	Ratio	Change	Purpose
2025-12-24Amended	CCP Japan Ltd2025-12-24 · amended	0.24%	new	Pure investment
2025-12-24Amended	CJP III GP Ltd.2025-12-24 · amended	39.20%	new	Pure investment
2025-09-25Amended	Masaki Nonaka2025-09-25 · amended	29.69%	-0.78pp	Participation in management; Stable shareholder
2024-12-20Amended	Masaki Nonaka2024-12-20 · amended	30.47%	+0.84pp	Participation in management; Stable shareholder
2024-06-24Amended	Masaki Nonaka2024-06-24 · amended	29.63%	no change	Participation in management; Stable shareholder
2024-06-24Amended	Masaki Nonaka2024-06-24 · amended	29.63%	-0.03pp	Participation in management; Stable shareholder
2024-06-24Amended	Masaki Nonaka2024-06-24 · amended	29.66%	no change	Participation in management; Stable shareholder
2024-06-24Amended	Masaki Nonaka2024-06-24 · amended	29.66%	-0.01pp	Participation in management; Stable shareholder
2024-06-24Amended	Masaki Nonaka2024-06-24 · amended	29.67%	no change	Participation in management; Stable shareholder
2024-06-24Amended	Masaki Nonaka2024-06-24 · amended	29.67%	no change	Participation in management; Stable shareholder
2024-06-24Amended	Masaki Nonaka2024-06-24 · amended	29.67%	-0.66pp	Participation in management; Stable shareholder
2024-06-24Amended	Masaki Nonaka2024-06-24 · amended	30.33%	-0.14pp	Participation in management; Stable shareholder
2024-06-24Amended	Masaki Nonaka2024-06-24 · amended	30.47%	new	Participation in management; Stable shareholder

Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.